![]() |
By Robert Fiddaman Dip.Couns MOC & MSFTR (about the author) Page 2 of 2 page(s)
In it, they wrote:
The burden of falciparum malaria remains as great as ever, and, as has probably always been the case, it is carried mainly by tropical Africa. Of the various means available for the control of malaria, the use of effective drugs remains the most important and is likely to remain so for a considerable time to come.
And what would that 'effective drug' be?
Lapdap - The outcome of a successful partnership between GlaxoSmithKline and The University of Liverpool - Coincidently where Sir Alisdair Breckenridge was Professor of Clinical Pharmacology.
Not so successful now Lapdap has been linked to reductions in hemoglobin levels in patients which can lead to anemia!
Alisdair Breckenridge is currently Chairman of the MHRA. The regulator that 'regulates' the drugs you and I take.
He has also robustly denied that there is a problem with GlaxoSmithKline's antidepressant Seroxat.
1 | 2
http://fiddaman.blogspot.com/
The views expressed in this article are the sole responsibility of the author
and do not necessarily reflect those of this website or its editors.
Contact Author |
Contact Editor |
View Authors' Articles |
| No comments |
Want to post your own comment on this Article?
|
||||
Tell a Friend:
|
Copyright © 2002-2009, OpEdNews |